bosutinib,
SKI-606,
SKI606,
Bosutinib,
380843-75-4,
SKI-606,
Bosutinib (SKI-606),
SKI 606,
SKI606,
BOSULIF,
UNII-5018V4AEZ0,
4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile,
4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile,
CHEMBL288441,
4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile,
CHEBI:39112,
5018V4AEZ0,
MFCD07367846,
1391063-17-4,
4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinoline-3-carbonitrile,
4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile,
Q-200745,
4-(2,4-dichloro-5-methoxyphenylamino)-6-methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinoline-3-carbonitrile,
Bosutinib (USAN),
Bosutinib [USAN:INN],
NCGC00241107-01,
Bosulif(R),
DB8,
WAY-173606,
Bosutinib,SKI-606,
PubChem22404,
Bosutinib (SKI606),
Bosutinib(SKI-606),
PF-5208763,
Bosutinib - SKI-606,
EC 700-455-1,
AC1NS5P1,
MLS006011212,
SCHEMBL158390,
BDBM4552,
GTPL5710,
QCR-26,
Bosutinib, >=98% (HPLC),
EX-A391,
SYN1025,
UBPYILGKFZZVDX-UHFFFAOYSA-N,
BCPP000318,
HMS2043A22,
HMS3244A03,
HMS3244A04,
HMS3244B03,
HMS3651C03,
K00615a,
AOB87309,
BCP01782,
ABP000235,
AN-465,
SK 606,
SK-606,
ZINC22448983,
AKOS015902521,
AC-2413,
API0024729,
BCP9000446,
CCG-208129,
CS-0118,
DB06616,
PB30881,
RL03452,
NCGC00241107-03,
NCGC00241107-05,
AK544289,
AS-11064,
BC644818,
HY-10158,
SC-23008,
SMR002530350,
AB0008633,
FT-0656231,
S1014,
SW220197-1,
X4840,
A25014,
D03252,
Q-4427,
AB01565836_03,
843B754,
Bosutinib|380843-75-4|SKI606|SKI 606,
SR-01000941572,
I14-1974,
J-519931,
SR-01000941572-1,
BRD-K99964838-001-01-0,
BRD-K99964838-001-06-9,
3-Quinolinecarbonitrile, 4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-,
4-(2,4-dichloro-5-methoxy-anilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile,
4-(2,4-Dichloro-5-methoxy-phenylamino)-6-methoxy-7-[3-(4-methyl-piperazin-1-yl)propoxy]quinoline-3-carbonitrile,
SKI-606;4-(2,4-Dichloro-5-methoxy-phenylamino)-6-methoxy-7-[3-(4-methyl-piperazin-1-yl)-propoxy]-quinoline-3-carbonitrile,
Bortezomib,
Bosutinib monohydrate,
Bosutinib Isomer,
bosutinib hydrate,
Bosutinib [USAN],
D0OB0F,
xy]-3-quinolinecarbonitrile,
cc-357,
C26H29Cl2N5O3,
Bosutinib Isomer 1, Free Base,
ACN-040494,
CID5328940,
CS-T-07791,
Bosutinib (BCR-ABL inhibitor 3rd gen),
A2149,
A10161,
C471992,
4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propo,
4-(3,5-Dichloro-4-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile,